Works matching IS 23663987 AND DT 2021 AND VI 4 AND IP 2
Results: 20
Masthead (Adv. Therap. 2/2021).
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202170004
- Publication type:
- Article
Targeted Therapy: Dendrimer‐Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy (Adv. Therap. 2/2021).
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202170003
- By:
- Publication type:
- Article
VCAM‐1‐Targeted Gene Delivery Nanoparticles Localize to Inflamed Endothelial Cells and Atherosclerotic Plaques.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000196
- By:
- Publication type:
- Article
Strategy to Enhance Dendritic Cell‐Mediated DNA Vaccination in the Lung.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000228
- By:
- Publication type:
- Article
Near Infrared Photo‐Antimicrobial Targeting Therapy for Candida albicans.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000221
- By:
- Publication type:
- Article
Human Ferritin Platform and Its Optimized Structures to Enhance Anti‐Cancer Immunity.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000208
- By:
- Publication type:
- Article
Inorganic Nanomaterials for Photothermal‐Based Cancer Theranostics.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000207
- By:
- Publication type:
- Article
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000203
- By:
- Publication type:
- Article
Batch Culture Formulation of Live Biotherapeutic Products.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000226
- By:
- Publication type:
- Article
Macrocyclic Peptide Inhibitor of PD‐1/PD‐L1 Immune Checkpoint.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000195
- By:
- Publication type:
- Article
Precision in Thermal Therapy: Clinical Requirements and Solutions from Nanotechnology.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000193
- By:
- Publication type:
- Article
Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000172
- By:
- Publication type:
- Article
A Review of the Current State of Nanomedicines for Targeting and Treatment of Cancers: Achievements and Future Challenges.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000186
- By:
- Publication type:
- Article
Dendrimer‐Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000181
- By:
- Publication type:
- Article
Peritumoral Delivery of Docetaxel‐TIPS Microparticles for Prostate Cancer Adjuvant Therapy.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000179
- By:
- Publication type:
- Article
One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000165
- By:
- Publication type:
- Article
Combining Photothermal Therapy‐Induced Immunogenic Cell Death and Hypoxia Relief‐Benefited M1‐Phenotype Macrophage Polarization for Cancer Immunotherapy.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000191
- By:
- Publication type:
- Article
PEGylation of Recombinant Human Deoxyribonuclease I Provides a Long‐Acting Version of the Mucolytic for Patients with Cystic Fibrosis.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000146
- By:
- Publication type:
- Article
Adenoviral Mediated Delivery of OSKM Factors Induces Partial Reprogramming of Mouse Cardiac Cells In Vivo.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000141
- By:
- Publication type:
- Article
Id1 and Id3 Are Regulated Through Matrix‐Assisted Autocrine BMP Signaling and Represent Therapeutic Targets in Melanoma.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 2, p. 1, doi. 10.1002/adtp.202000065
- By:
- Publication type:
- Article